TLXNasdaq

Telix Pharmaceuticals Ltd

Pharmaceutical Preparations · C3 · CIK 2007191

Telix Pharmaceuticals develops and commercializes targeted radiopharmaceutical therapeutics and diagnostics

$4.02B

Market cap

$11.87

Last close

+0.3%

+9.3%

255K

Volume

Price$11.87-28.1%· 1Y

Jul 2L $6.41 · H $16.92Jul 2

Total filings

Jul 2, 2026

Last filing

12/31

Fiscal year end

Similar companies

Comparable business profile · signals at a glance